Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 7/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.52 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.52 |
| ▸ | TOP1 | P11387 | 1/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | CTSC | P53634 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2782846 | 0.81 | CYP2A6 (0.45) | CYP2A6CYP2E1CYP2B6TOP1KCNH2 | |
| SCHEMBL27989815 | 0.81 | CYP2A6 (0.74) | CYP2A6CYP2E1CYP2B6CYP17A1CYP11B1 | |
| SCHEMBL27527131 | 0.80 | CYP2A6 (0.45) | KIF11CYP2A6CYP2E1CYP2B6TOP1 | |
| SCHEMBL12548175 | 0.78 | KIF11 (0.54) | KIF11CYP2A6CYP2E1CYP2B6CYP17A1 | |
| SCHEMBL13410633 | 0.78 | KIF11 (0.78) | KIF11MAOB | |
| SCHEMBL29914837 | 0.78 | KIF11 (0.78) | KIF11MAOB | |
| SCHEMBL197238 | 0.78 | KIF11 (0.78) | KIF11MAOB | |
| SCHEMBL28461267 | 0.77 | TOP1 (0.48) | KIF11CYP2A6CYP2E1CYP2B6TOP1 | |
| SCHEMBL2125063 | 0.75 | CYP2A6 (0.72) | CYP2A6CYP2E1CYP2B6CYP17A1CYP11B1 | |
| SCHEMBL27523459 | 0.75 | CYP2A6 (0.58) | CYP2A6CYP2E1CYP2B6TOP1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118459506-A | Iridium complex capable of preparing efficient device by using 4-pyrimidine formic acid as auxiliary ligand in solution | 云南师范大学 | 2024-08-09 | — | — | CN | claimed |
| US-9048031-B2 | Method of and printable compositions for manufacturing a multilayer carbon nanotube capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2015-06-02 | — | — | US | claimed |
| US-20140182099-A1 | Method of and Printable Compositions for Manufacturing a Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2014-07-03 | — | — | US | claimed |
| WO-2011103025-A1 | MULTILAYER CARBON NANOTUBE CAPACITOR AND METHOD OF AN PRINTABLE COMPOSITIONS FOR MANUFACTURING A MULTILAYER CARBON NANOTUBE CAPACITOR | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2011-08-25 | — | — | WO | claimed |
| US-20110205688-A1 | Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2011-08-25 | — | — | US | claimed |
| US-20110204020-A1 | Method of and Printable Compositions for Manufacturing a Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2011-08-25 | — | — | US | claimed |
| CN-118459506-A | Iridium complex capable of preparing efficient device by using 4-pyrimidine formic acid as auxiliary ligand in solution | 云南师范大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-118459506-A | Iridium complex capable of preparing efficient device by using 4-pyrimidine formic acid as auxiliary ligand in solution | 云南师范大学 | 2024-08-09 | — | — | CN | disclosed |
| US-20160086741-A1 | Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECH WORLDWIDE INC (US) | 2016-03-24 | — | — | US | disclosed |
| US-9048031-B2 | Method of and printable compositions for manufacturing a multilayer carbon nanotube capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-20140182099-A1 | Method of and Printable Compositions for Manufacturing a Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140139975-A1 | Multilayer Carbon Nanotube Capacitor | NTHDEGREE TECHNOLOGIES WORLDWIDE INC. (US) | 2014-05-22 | — | — | US | disclosed |
| EP-1668058-B1 | CONJUGATED POLYMERS, THEIR PREPARATION AND USE THEREOF | MERCK PATENT GMBH (DE) | 2012-10-24 | — | — | EP | disclosed |
| US-20080249137-A1 | PPAR active compounds | PLEXXIKON INC | 2008-10-09 | — | — | US | disclosed |
| US-20080249137-A1 | PPAR active compounds | PLEXXIKON INC | 2008-10-09 | — | — | US | disclosed |
| EP-1940767-A2 | PPARACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007030567-A2 | PPARACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007030567-A2 | PPARACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| EP-1668058-A1 | CONJUGATED POLYMERS, THEIR PREPARATION AND USE THEREOF | MERCK PATENT GmbH (DE) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005030828-A1 | CONJUGATED POLYMERS, THEIR PREPARATION AND USE THEREOF | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249137-A1 | PPAR active compounds | PPARG, PPARA, PPARD | KIF11 4491/4885CYP2A6 887/4885CYP2E1 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.